HOME >> MEDICINE >> NEWS
Wrinkled membranes create novel drug-delivery system

A University of Illinois scientist studying how membranes wrinkle has discovered a novel system for on-demand drug delivery.

Sahraoui Chaieb, a professor of mechanical and industrial engineering, has created temperature-sensitive capsules that can release drugs on demand. The capsules, which can range in size from 10 to 100 microns, can be tuned to deliver drugs at different rates. Chaieb reports his findings in the Feb. 17 issue of the journal Physical Review Letters.

To make the capsules, Chaieb begins by confining a drug inside lipid bilayer membranes. Some of the lipids are then "sewn together" through a polymerization process. Cooling the capsules by 10 degrees Celsius causes the capsules to crumple and collapse like deflated beach balls, releasing the drug.

"The release rate can be controlled by the amount of wrinkling that occurs," said Chaieb, who also is a professor of bioengineering and a researcher at the Beckman Institute for Advanced Science and Technology. "And the amount of wrinkling is dependent upon the degree of membrane polymerization that took place."

One problem that remains is how to cool the capsules without harming the surrounding tissue. The solution, Chaieb said, might lie in newly discovered nanoparticles that can be chilled through magnetic cooling.

Chaieb and colleagues at Illinois are exploring ways to coat the capsules with the nanoparticles. When exposed to a magnetic field, the nanoparticles would cool down and remove heat from the capsules. The capsules would then wrinkle and release the drug.


'"/>

Contact: James E. Kloeppel, Physical Sciences Editor
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
13-Feb-2006


Page: 1

Related medicine news :

1. RAND, Health Dialog form alliance to create tools to evaluate health-care quality and efficiency
2. Spanish project AmIVital creates intelligent communication devices for elderly and disabled people
3. ASU, Walter Reed researchers create prosthesis of the future
4. Head and neck cancer vaccine targets proteins to create immune response
5. Scientists create dual-modality microbeads to improve identification of disease biomarkers
6. St. Jude, El Salvador create research ethics committee
7. Bacteria could make new library of cancer drugs that are too complex to create artificially
8. NCI creates network of Clinical Proteomic Technology Centers for cancer research
9. UCSD researchers create roadmap to integrin activation
10. Young brainy students create world first
11. Baylor Institute for Immunology research receives $3 million grant to create cancer vaccines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... 2017 , ... Global Lyme Alliance (GLA), the leading 501(c)(3) ... today announced the appointment of Timothy J. Sellati, Ph.D. as its Chief Scientific ... 20 years of research experience with Lyme and other tick-borne diseases. He has ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , ... wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, Keeping Up ... , In the competitive world of drug and device marketing and promotion, drug ... FDA rules. , The FDA has issued two draft guidances that are the ...
(Date:9/21/2017)... ... , ... Bill Howe Plumbing’s mission is to create an employee friendly company, ... For over 37 years, they have operated with their mission at the foundation and ... Diego. They were chosen as the Best San Diego plumber in 2016, named a ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for ... today the election of Yie-Hsin Hung to the Board of Directors. , “The ... of Directors. Ms. Hung is an invaluable addition to our team,” said Vincent Strully, ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/7/2017)... Sept. 7, 2017  Eli Lilly and Company ... to streamline operations to more efficiently focus resources ... cost structure. Global workforce reductions, including those from ... to impact approximately 3,500 positions. ... annualized savings of approximately $500 million that will ...
Breaking Medicine Technology:
Cached News: